Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Both mouse and rat models are effective for testing alopecia areata treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Mice with autoimmune hair loss showed signs of heart problems.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Wigs significantly improve the well-being of people with severe hair loss.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Allergies and atopic conditions may increase the risk of developing alopecia areata.

Betamethasone can effectively treat alopecia areata.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Certain gene variations increase the risk of alopecia areata in Koreans.